Program Director Internal Medicine
Resume:
CURRICULUM VITAE
MEHMET CILINGIROGLU, M.D., FSCAI, FACC, FESC, FAHA, FACP
Professor of Medicine, Surgery and Biomedical Engineering BIOGRAPHICAL
Name: Mehmet Cilingiroglu Birth Date: 02/04/1970
Gender: Male Languages: English, Turkish
Home Address: Birthplace: Denizli/TURKEY
13082 Lumen Way
San Diego, CA 92130
Cell Phone: 858-***-**** Citizenship: U.S.A., Turkish Business Address: E-Mail Address:
As above ******************@*****.***
EDUCATION and TRAINING
UNDERGRADUATE
Sep.1983-June 1986 Antalya High School
Bachelor of Science, Cam Laude, 06/30/1986
Antalya, Turkey
2
GRADUATE
Sep. 1986- July 1993 Medical School
Doctor of Medicine, Awarded 07/31/1993 with Honors Hacettepe University Faculty of Medicine in English Ankara, Turkey
POSTGRADUATE
Sep. 1993- June 1994 Internship in Internal Medicine Hacettepe University Faculty of Medicine
Ankara, Turkey
July 1994- June1995 Internship in Internal Medicine Medical College of Virginia /Virginia Commonwealth University Program Director: Michael Edmond, MD, MPH
Richmond, VA
July 1995- June 1997 Residency in Internal Medicine/Virginia Commonwealth University Medical College of Virginia
Program Director: Michael Edmond, MD, MPH
Richmond, VA
July 2000- June 2004 American Heart Association Bugher Fellow in Molecular Cardiology Baylor College of Medicine/Michael DeBakey Heart Center Program Director: Robert Roberts, MD
Houston, TX
July 2004- June 2006 Fellow in Interventional Cardiology Texas Health Sciences Center in San Antonio
Janey Briscoe Center for Cardiovascular Research
Program Director: Steven R. Bailey, MD
San Antonio, TX
Jan. 2010- Dec. 2010 Structural Heart Disease Fellow Evanston Hospital/NorthShore University
Program Director: Ted Feldman, MD
Evanston, IL
APPOINTMENTS and POSITIONS
ACADEMIC
July 2004-June 2006 Instructor, Interventional Cardiology University of Texas Health Sciences Center in San Antonio San Antonio, TX
3
Oct. 2006-Sep. 2007 Assistant Professor of Medicine Division of Cardiovascular Diseases
University of Arkansas for Medical Sciences
Little rock, AR
Apr. 2008- Aug. 2010 Assistant Professor of Medicine Division of Cardiovascular Diseases
Director of Translational Research
Director of Interventional Research
University of Cincinnati Medical Center
Cincinnati, OH
Mar. 2011-June 2011 Assistant Professor of Medicine Director of Structural Heart Disease
Director of Interventional Cardiology Research
University of Maryland School of Medicine
Baltimore, MD
Jan. 2012-Dec. 2012 Associate Professor of Medicine University of Pittsburgh Medical Center
Heart and Vascular Institute
Pittsburgh, PA
July 2013- Mar. 2017 Associate Professor of Medicine Division of Cardiology
University of Arkansas for Medical Sciences
Little Rock, AR
May 2017-June 2019 Professor of Medicine
Division of Cardiology
University of Arkansas for Medical Sciences
Little Rock, AR
June 2014-June 2020 Adjunct Professor of Medicine
Division of Cardiology
Koc University, School of Medicine
Istanbul, Turkey
May 2015-July 2020 Adjunct Associate Professor of Medicine Division of Cardiology
UTHSCSA
San Antonio, TX
Aug. 2020-Present Adjunct Professor of Medicine
Division of Cardiology
UTHSCSA
4
San Antonio, TX
Apr. 2016-Present Adjunct Associate Professor of Biomedical Engineering University of Arkansas School of Biomedical Engineering Fayetteville, AR
Jan. 2019- Aug. 2020 Professor of Medicine
Division of Cardiology
Bahcesehir University, School of Medicine
Istanbul, Turkey
Jan. 2020-Present Adjunct Professor of Medicine
Division of Cardiology (Cardio-Oncology)
University of Texas MD Anderson Cancer Center
Houston, TX
Sep. 2020-May 2022 Visiting Professor of Medicine
University of California Irvine, School of Medicine Irvine, CA
Oct. 2020-Oct. 2021 Professor of Medicine
University of Hawaii John Burns School of Medicine Cardiology Section
Honolulu, HI
Dec. 2020-March 2022 Professor of Medicine
University of Arizona, College of Medicine
Tucson, AZ
Sep. 2023-Present Clinical Adjunct Full Professor
University of the Incarnate Word School of
Osteopathic Medicine
San Antonio, TX
NON-ACADEMIC CLINICAL AFFILIATIONS (HOSPITAL AND CLINIC) July 1997- June 2000 Medical Director and Internal Medicine Practice Boydton Medical Center
Boydton, VA
July 2006- Sept. 2007 Interventional Cardiology Staff Physician Cardiology Associates
Pine Bluff, AR
Oct. 2008- Dec. 2008 Interventional Cardiology Staff Physician 5
Bon Secours Health System
Richmond, VA
Mar. 2008- Dec. 2009 University of Cincinnati Medical Center Section of Interventional Cardiology
Director of Translational Research
Director of Interventional Cardiology Research
Interventional Cardiologist
Cincinnati, OH
Apr. 2011-June 2011 University of Maryland Medical Center Director of Structural Heart Interventions
Director of Interventional Cardiology Research
Section of Interventional Cardiology
Baltimore, MD
Nov. 2011-June 2012 University of Pittsburgh Medical Center Shaddy Side Hospital UPMC
Interventional Staff Cardiologist
Pittsburgh, PA
July 2012-June 2019 Arkansas Heart Hospital
Interventional Cardiology, Staff Physician
Medical Director of Peripheral Vascular Interventions Little Rock, AR
Oct. 2020-May 2021 Southern Arizona Veterans Health System Interventional Cardiology/Structural Heart Interventionalist Tucson, AZ
Oct. 2021-Nov. 2023 Doctors Hospital of Laredo
Vice Chair of Medicine
Medical Director of Cardiology
Director of Structural Heart Disease
Director of Cardiac Cath Lab
Laredo, TX
Nov. 2023-Present Doctors Hospital of Laredo
Chair of Medicine
Director of Cardiology
Director of Structural Heart Disease
Director of Cardiac Cath lab
Laredo, TX
6
CERTIFICATION and LICENSURE
SPECIALTY CERTIFICATION:
1997, 2007, 2021 Diplomate, American Board of Internal Medicine #174***-****, 2013 Diplomate, Subspecialty of Cardiovascular Diseases #174***-****, 2014 Diplomate, Subspecialty of Interventional Cardiology #174***-**** Diplomate, American Board of Vascular Medicine-Endovascular Medicine
MEDICAL PROFESSIONAL LICENSURE:
VA 010******* issued: 07/01/1997 Expired: 02/28/2010 MD D72339 issued: 05/19/2011 Expired: 09/30/2016
AR E4501 issued: 04/08/2005 Expires: 02/29/2026
PA MD444461 Issued: 10/31/2011 Expired: 12/31/2018 TX K8730 Issued: 11/05/1999 Expires: 05/31/2024
FL ME100947 Issued: 02/05/2008 Expires: 01/31/2024 OH 35.091024 Issued: 01/18/2008 Expired: 04/01/2019 UT 326-***-**** Issued: 10/17/1996 Expired: 01/31/1998 IL 036124473 Issued: 10/06/2009 Expired: 07/31/2014 HI 20660 Issued: 07/26/2019 Expires: 01/31/2026
CA C164574 Issued: 08/14/2019 Expires: 08/31/2024
WI 72113-20 Issued: 10/22/2019 Expires: 10/31/2023 LA 322362 Issued: 04/16/2020 Expires: 02/29/2024
OK 40021 Issued: 07/12/2022 Expires: 07/01/2024
MEMBERSHIPS in PROFESSIONAL and SCIENTIFIC SOCIETIES 1994 Member of American Medical Association
1999 Fellow of American College of Physicians
2005 Fellow of American College of Cardiology
2005 Fellow of American Heart Association
2005 Fellow of European Society of Cardiology
2006 Fellow of Society of Cardiovascular Angiography and Interventions HONORS
1993 Graduated top 1%, Hacettepe University, Faculty of Medicine with Honors.
1993 Ranked top 1% in Turkish National Resident Placement Examination.
2003 Best presenter at the Pfizer abstract competition, American College of Cardiology in Chicago.
7
2003 Best clinical research award, department of medicine, section of cardiology, Baylor College of Medicine.
2003 First place award in the department of medicine research symposium Baylor College of Medicine.
2003 Michael E. DeBakey outstanding young investigator in clinical research award, Baylor College of Medicine.
2004 First place award in clinical research at the department of medicine research symposium, Baylor College of Medicine.
2005 First Place Award, Society of Cardiovascular Angiography and Coronary Interventions/General Electric fellowship grant award winner, $20,000.
2005 First place award in population science poster presentation at the AHA meeting, Dallas, TX.
2009 Jeremiah Stamler Distinguished Young Investigator Finalist, Chicago, IL.
2009 CRT Emerging Young Leadership Award, Washington, DC. 2010 Jeremiah Stamler Distinguished Young Investigator Finalist, Chicago, IL.
2012 Jeremiah Stamler Distinguished Young Investigator Finalist, Chicago, IL.
2020 CRT, Finalist, Cardiac Innovation Competition “VH IVOCT in detection of different components of the atherosclerotic plaque in vivo”.
PUBLICATIONS
Peer-reviewed articles
1. Ke M, Cilingiroglu M, Otvos JD, Ballantyne CM, Marian AJ, Chan L.
“Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure and metabolism”. Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2748-53.
2. Cilingiroglu M, Ballantyne C. “Endothelial lipase and cholesterol metabolism”. Curr Atheroscler Rep. 2004 Mar;6(2):126-30. 3. Cilingiroglu M, Ozer K.“Oxidized LDL receptor (LOX-1) and its role in atherosclerosis”. Curr Atheroscler Rep., 2005 Mar;7(2):103-7. 4. Ozer K, Cilingiroglu M. “Vulnerable plaque: definition, detection, treatment, and future implications.” Curr Atheroscler Rep., 2005 Mar;7(2):121-6. 5. Cilingiroglu M, Ozer K. “Optical coherence tomography and its use in detection of vulnerable plaque”. Curr Atheroscler Rep., 2006 Mar;8(2):140- 3.
8
6. Cilingiroglu M, Oh JH, Sugunan B, Kemp NJ, Kim J, Lee S, Zaatari HN, Escobedo D, Thomsen S, Milner TE, Feldman MD. “Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography”. Catheter Cardiovasc Interv. 2006 Jun;67(6):915-23. 7. Cilingiroglu M, Elliott J, Patel D, Tio F, Matthews H, McCasland M, Trauthen B, Elicker J, Bailey SR. “Long-term effects of novel biolimus eluting DEVAXX AXXESS plus nitinol self-expanding stent in a porcine coronary model”. Catheter Cardiovasc Interv. 2006 Aug;68(2):271-9. 8. Toursarkissian B, Cilingiroglu M, Hagino R, Wholey M, Veale L “Subintimal snare-assisted dissection for iliac recanalization: A Potentially useful tool”. Vascular Disease Management, 2007 Mar;4:(2); 41-44. 9. Sanghi P, Virmani R, DO D, Erickson J, Elliott J, Cilingiroglu M, Matthews H, Kazi M, Ricker R, Bailey SR. “A Comparative evaluation of the healing response after femoral artery closure using angioseal STS Plus and starclose in a porcine model”. J Interv Cardiol. 2008 Aug;21(4):329-36.
10. Oh J, Feldman MD, Kim J, Sanghi P, Do D, Mancuso JJ, Kemp N, Cilingiroglu M, Milner TE. “Detection of macrophages in atherosclerotic tissue using magnetic nanoparticles and differential phase optical coherence tomography”. J Biomed Opt. 2008 Sep-Oct;13(5):054006. 11. Cilingiroglu M, Waheed MA, Akkus N. “Coronary Angiography in a Patient with Situs Inversus Totalis”. Anatolian Journal of Cardiology. 2008 Dec;8(6):455-6.
12. Cilingiroglu M, Uzunpinar A. “Pulmonary arterial hypertension”. Curr Atheroslcer Rep., 2009 Mar;11(2):139-45.
13. Cilingiroglu M, Khan F. “DES and vulnerable plaque” Curr Atheroscler Rep., 2009 Mar;11(2):146-8.
14. Cilingiroglu M, Elliott J, Sangi P, Matthews H, Tio F, Trauthen B, Elicker J, Bailey SR. “In-vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model”. EuroIntervention. 2009 Jan;4(4):534-41.
15. Rahman S, Abdul-Waheed M, Helmy T, Huffman LC, Koshal V, Guitron J, Merrill WH, Lewis DF, Dunlap S, Shizukuda Y, Weintraub NL, MD, Meyer C, Cilingiroglu M. “Spontaneous left main coronary artery dissection complicated by pseudoaneurysm formation in pregnancy: role of CT coronary angiography”. J Cardiothorac Surg. 2009 Apr 1;4:15. 16. Cilingiroglu M, Akkus N. “Intravascular imaging of ruptured plaque by virtual histology intravascular ultrasound in acute ST elevation myocardial infarction”. Anatolian Journal of Cardiology, 2009 Aug;9(4):349-50. 17. Hakeem A, Cilingiroglu M, Leesar MA. “Hemodynamic and intravascular ultrasound assessment of myocardial bridging: fractional flow reserve paradox: dobutamine vs. adenosine”. Catheter Cardiovasc Interv. 2010 Feb 1;75(2):229-36.
18. Chen SN, Cilingiroglu M, Todd J, Lombardi R, Willerson JT, Gotto AM, Ballantyne CM, Marian AJ. “Putative functional single nucleotide 9
polymorphisms as determinants of plasma high-density lipoprotein- cholesterol levels”. BMC Med Genet. 2009 Oct 30;10:111. 19. Cilingiroglu M, Chilakapati V, Dunlap S, Leesar MA. “Sirolimus-eluting stent fractures leading to restenosis in cardiac allograft vasculopathy”. Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):120-3.
20. Khan FM, Kulasizoglu B, Cilingiroglu M. “Depression and coronary heart diseases; can a broken heart can truly break your heart?”. Curr Atheroscler Rep., 2010 Mar;12(2):105-9.
21. Hakeem A, Bhatti S, Cilingiroglu M. “The spectrum of atherosclerotic coronary artery disease in HIV patients”. Curr Atheroscler Rep. 2010 Mar;12(2):119-24.
22. Bhatti S, Hakeem A, Cilingiroglu M. “Lp-PLA2 as a marker of cardiovascular diseases”. Curr Atheroscler Rep., 2010 Mar;12(2):140-4. 23. Hakeem A, Bhatti S, Arif I, Effat M, Cilingiroglu M. “Fibrinolytic therapy for very late stent thrombosis--is it a viable option?”. Cardiovasc Revasc Med. 2010 Oct-Dec;11(4):264.e13-5.
24. Cilingiroglu M, Bailey SR. “Drug-eluting stents and endothelial dysfunction” Interventional Cardiology 2010;2:45-56. 25. Cilingiroglu M, Feldman TE. “Update on percutaneous mitral valve interventions: Overview of new approaches”. Vascular Disease Management 2010;7:E126-E134.
26. Greenage M, Kulaksizoglu B, Cilingiroglu M, Ali R. “ The role of anxiety and emotional stress as a risk factor in treatment-resistant hypertension”. Curr Atheroscler Rep. 2011 Apr;13(2):129-31.
27. Feldman TE, Cilingiroglu M. “Percutaneous leaflet repair and annuloplasty for mitral regurgitation”. J Am Coll Cardiol. 2011 Feb 1;57(5):529-37. 28. Hakeem A, Helmy T, Munsif S, Bhatti S, Mazraeshahi R, Cilingiroglu M, Effat M, Leesar M, Arif I. “Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: A comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients”. Catheter Cardiovasc Interv. 2011 Feb 15;77(3):343-55.
29. Cilingiroglu M, Feldman TE, Salinger MH, Levisay J, Turi ZG.
“Fluoroscopically-guided micropuncture femoral artery access for large caliber sheath insertion”. Journal of Invasive Cardiology. 2011 Apr;23(4):157-61.
30. Sanchez CE, Cilingiroglu M, Leesar MA, Costea A. “ Biventricular pacing leading to coronary stent fracture”. Tex Heart Inst J. 2011;38(2):208-9. 31. Cilingiroglu M, Rahman S, Helmy T, Seshiah P. “Spontaneous coronary artery dissection possibly associated with the use of clonidine transdermal patch”. Archives of The Turkish Society of Cardiology. 2011 Apr;39(3):224- 7.
32. Cilingiroglu M, Lather N, Youseff A, Helmy T. “ST elevation myocardial infarction due to spontaneous thrombus in left anterior descending artery in a young patient with HIV Infection”. Archives of The Turkish Society of Cardiology 2011 Jun;39(4):308-11.
10
33. Cilingiroglu M, Salinger M, Zhao D, Feldman TE. “Figure-of-Eight” sutures to achieve hemostasis after removal of large-caliber femoral venous sheaths". Catheterization and Cardiovascular Interventions. 2011 Jul 1;78(1):155-60.
34. Hakeem A, Karmali K, Larue S, Bhatti S, Chilakapati V, Samad Z, Rothcline M, Cilingiroglu M, Leesar M. “Clinical presentation and outcomes of drug eluting stent associated coronary aneurysms (DESCA). Eurointerventions. 2011 Aug;7(4):487-96.
35. Cilingiroglu M, Hakeem A. “Fate of mitral regurgitation following transcatheter aortic valve implantation: The achilles heel of core valve?” Catheter Cardiovasc Interv. 2011 Oct 1;78(4):645-6. 36. Cilingiroglu M, Hakeem A.“Ischemia Driven Percutaneous Coronary Intervention for Chronic Total Occlusions – Is There Light at the End of the Tunnel?”. Catheterization and Cardiovascular Interventions. 2011;78:344– 345.
37. Cilingiroglu M, Hakeem A. “A percutaneous scabbard for the scimitar” Catheter Cardiovasc Interv. 2011;78:692–693.
38. Cilingiroglu M, Gupta A. “LAA Closure paradigm: are we there yet?” Catheter Cardiovasc Interv. 2011 Nov 15;78(6):974-5. 39. Cilingiroglu M, Hakeem A. “Revisiting the "Dented Bladder" - A bona fide sign of retroperitoneal bleed”. Catheter Cardiovasc Interv. 2011 Jan 1;79(1):166.
40. Akkuş NI, Cilingiroğlu M. “[Comment on: Practical tips for the measurement of fractional flow reserve (FFR) (Turk Kardiyol Dern Ars 2011;39:433-435)]”. Turk Kardiyol Dern Ars. 2012 Jan;40(1):111; author reply 112.
41. Akkus NI, Bahadur F, Cilingiroglu M. “Successful percutaneous revascularization of totally occluded left subclavian artery using orbital atherectomy”. Cardiovasc Revasc Med. 2012 Jul-Aug;13(4):234-7. 42. Cilingiroglu M, Akkus N. “ Embolization of a PORT-A-CATH device in the main pulmonary artery and its percutaneous extraction in a patient with pinch-off syndrome”. Archives of The Turkish Society of Cardiology 2012 Mar;40(2):162-4.
43. Cilingiroglu M, Salinger M. “Percutaneous mitral valve repair with MitraClip”. Archives of The Turkish Society of Cardiology 2012 Mar;40(2):174-80.
44. Cilingiroglu M. “Asymptomatic carotid artery stenting: filter or not filter”. Catheter Cardiovasc Interv. 2012 Jul 1;80(1):120.
45. Marmagkiolis K, Hakeem A, Cilingiroglu M, Bailey SR, Ruiz C, Hijazi ZM, Herrmann HC, Zajarias A, Goldberg SL, Feldman T. “The Society for Cardiovascular Angiography and Interventions Structural Heart Disease Early Career Task Force Survey Results - Endorsed by the Society for Cardiovascular Angiography and Interventions”. Catheter Cardiovasc Interv. 2012 Oct 1;80(4):706-11.
11
46. Cilingiroglu M, Akkus N, Sethi S, Modi KA. “Large pericardial effusion induced by minoxidil”. Archives of The Turkish Society of Cardiology 2012 Apr;40(3):255-8.
47. Cilingiroglu M. “Clipping the neck of pseudoaneurysm”. Catheter Cardiovasc Interv. 2012 Nov 1;80(5):876.
48. Cilingiroglu M, Hakeem A, Feldman MD, Wholey M. “Optical Coherence Tomography Imaging In Asymptomatic Patients With Carotid Artery Stenosis”. Cardiovascular Revascularization Medicine 2013 Jan- Feb;14(1):53-6.
49. Cilingiroglu M, Hakeem A. “Drug-eluting balloons: are they safer?” Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1227. 50. Cilingiroglu M, Akkus N. “Right Sided Scimitar Syndrome in a patient with A Single Aortic Trunk and Coronary-Cameral Venous Fistula”. Rev Port Cardiol. 2013 Jan;32(1):63-6.
51. Cilingiroglu M, Marmagkiolis K, Wholey M. “Carotid Stenting: Update”. Future Cardiol. 2013 Mar;9(2):193-7.
52. Gundogdu BM, Cilingiroglu M. “ Chronic inflammatory muscle diseases and risk of coronary artery disease”. Curr Atheroscler Rep. 2013 Mar;15(3):308.
53. Cilingiroglu M, Hakeem A. “3D Imaging of TCFA: Are We There Yet?” Catheter Cardiovasc Interv. 2013 Feb;81(3):550.
54. Cilingiroglu M. “Transcatheter aortic valve implantation: Time has arrived for repositionable, retrievable valves. Catheter Cardiovasc Interv. 2013 Feb 1;81(2):397-398.
55. Cilingiroglu M, Marmagkiolis K, Wholey MH. “Carotid artery stenting update”. Future Cardiol. 2013 Mar;9(2):193-7.
56. Marmagkiolis K, Brilakis ES, Hakeem A, Cilingiroglu M, Bilodeau L.
“Saphenous Vein Graft Perforation During Percutaneous Coronary Intervention. A Case Series”. J Invasive Cardiol. 2013 Mar;25(3):157-61. 57. Marmagkiolis K, Cilingiroglu M. “Intracardiac echocardiography--guided percutaneous mitral balloon valvuloplasty”. Rev Port Cardiol. 2013 Apr;32(4):337-9.
58. Cilingiroglu M, Marmagkiolis K. “Use of the Melody transcatheter pulmonary valve as a covered stent: pushing the envelope. Catheter Cardiovasc Interv. 2013 May;81(6):985-986.
59. Cilingiroglu M, Marmagkiolis K. “Percutaneous closure of multiple atrial septal defects: Do we have the ideal device yet?” Catheter Cardiovasc Interv. 2013 Jun 1;81(7):1243.
60. Cilingiroglu M, Rollefson WA, Mego D. “Percutaneous Implantation of A Parachute Device For Treatment of Ischemic Heart Failure: Mini Review”. Cardiovasc Revasc Med. 2013 May 22. doi:pii: S1553-8389(13)00052-3. 61. Cilingiroğlu M, Marmagkiolis K, Wholey M. “Successful recanalization of a left common iliac artery chronic total occlusion adjacent to an ectopic renal artery at the aortoiliac bifurcation”. Turk Kardiyol Dern Ars. 2013 Jun;41(4):347-50.
12
62. Marmagkiolis K, Alqoofi F, Asgar A, Boone RH, Cilingiroglu M. “Structural heart disease interventional training programs in Canada” Can J Cardiol. 2013 Nov;29(11):1524-6.
63. Cilingiroglu M, Marmagkiolis K. “Left atrial appendage closure: Does leak matter?” Catheter Cardiovasc Interv. 2013 Nov 15;82(6):1020. 64. Marmagkiolis K, Cilingiroglu M. "The Role of Invasive Hemodynamic Assessment During The Mitra-Clip Implantation". Int J Cardiol. 2013 Oct 12;168(5):4870-2.
65. Rahman S, Leesar T, Cilingiroglu M, Effat M, Arif I, Helmy T, Leesar MA.
“Impact of Kissing Balloon Inflations on the Main Vessel Stent Volume, Area, and Symmetry after Side-Branch Dilatation in Patients with Coronary Bifurcation Lesions: A Serial Volumetric Intravascular Ultrasound Study” JACC Cardiovasc Interv. 2013 Sep;6(9):923-31.
66. Cawich I, Marmagkiolis K, Cilingiroglu M. “Ocelot catheter for the treatment of long SFA occlusion” Catheter Cardiovasc Interv. 2014 Jan 1;83(1):144-7.
67. Hakeem A, Marmagkiolis K, Hacioglu Y, Uretsky B, Gundogdu B, Leesar M, Bailey SR, Cilingiroglu M. “Safety and Efficacy of Device Closure for Patent Foramen Ovale for Secondary Prevention of Neurological events: Comprehensive Systematic Review and Meta-analysis of Randomized Controlled Trials”. Cardiovasc Revasc Med. 2013 Nov- Dec;14(6):349-55.
68. Marmagkiolis K, Cilingiroglu M. "Radi pressure-wire rupture and embolization to the right common carotid artery after crossing a Bjork Shiley mechanical aortic valve”. J Invasive Cardiol. 2013 Oct;25(10):E191-3. 69. Marmagkiolis K, Lendel V, Cawich I, Cilingiroglu M. “Ocelot Catheter For the Recanalization of Lower Extremity Arterial Chronic Total Occlusion: Mini Review”. Cardiovasc Revasc Med. 2014 Jan;15(1):46-9. 70. Marmagkiolis K, Cilingiroglu M. “Hybrid use of melody valve: The best of both worlds?”. Catheter Cardiovasc Interv. 2013 Nov 1;82(5):833. 71. Marmagkiolis K, Cilingiroglu M. “Pharmacologic pretreatment in SVG interventions”. Catheter Cardiovasc Interv. 2014 Nov 1;84(5):856. 72. Akkus NI, Budeepalli J, Cilingiroglu M. “Immediate stent recoil in an anatomotic vein graft lesion and its treatment with a cutting balloon angioplasty” Rev Port Cardiol. 2013 Nov;32(11):935-9. 73. Tremmel JA, Patel R, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. “Commentary on Late Breaking Trials in Interventional Cardiology at ESC, VIVA, TCT, and AHA (Fall 2012) and ACC2013. Catheter Cardiovasc Interv. 2014 May 1;83(6):936-43.
74. Marmagkiolis K, Cilingiroglu M. “Conservative management of left main dissection: Breaking the taboo”. Catheter Cardiovasc Interv. 2014 Jan 1;83(1):69.
75. Marmagkiolis K, Lendel V, Cilingiroglu M. “EKOS ultrasound-accelerated catheter-directed thrombolysis for acutely occluded femoro-popliteal graft”. Cardiovasc Revasc Med. 2014 Jan;15(1):43-5.
13
76. Cilingiroglu M. “Mitral stenosis following MitraClip procedure: Is it preventable?”. Catheter Cardiovasc Interv. 2014 Feb;83(2):303-4. 77. Marmagkiolis K, Hakeem A, Cilingiroglu M. “Isolated right atrial infarction from occluded non-dominant right coronary artery. Rev Port Cardiol. 2014 Feb;33(2):123-4.
78. Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ, Grines CL, Singh M. “SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup”. Circulation. 2014 Jun 17;129(24):2610-26. 79. Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ, Grines CL, Singh M. “SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup”. J Am Coll Cardiol. 2014 Jul 22;64(3):335. 80. Marmagkiolis K, Lendel V, Best JF, Cilingiroglu M. “Management of Transradial Access complications in the catheterization laboratory”. Int J Cardiol. 2014 May 15;173(3):521-4.
81. Marmagkiolis K, Gobal F, Mego D, Cilingiroglu M, Rollefson W. “ Endovascular management of splenic arterial aneurysms”. Int J Cardiol. 2014 Jun 1;174(1):146-9.
82. Marmagkiolis K, Hakeem A, Choksi N, Al-Hawwas M, Edupuganti M, Leesar MA, Cilingiroglu M. “12-month Primary Patency Rates of Contemporary Endovascular Device Therapy for Femoro-Popliteal Occlusive Disease in 6024 Patients: Beyond Balloon Angioplasty”. Catheter Cardiovasc Interv. 2014 Oct 1;84(4):555-64.
83. Marmagkiolis K, Lendel V, Leesar MA, Feldman MD, Cilingiroglu M. “Use of Optical Coherence Tomography During Superficial Femaoral Artery Interventions”. J Invasive Card. 2014 May;26(5):220-3. 84. Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ, Grines CL, Singh M. “SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without On-Site Surgical Backup”. Catheter Cardiovasc Interv. 2014 Aug 1;84(2):169-87.
85. Marmagkiolis K, Cilingiroglu M. “ Have we found the optimal solution for
"Swiss Cheese" ASDs yet?” Catheter Cardiovasc Interv. 2014 Aug 1;84(2):211.
86. Tremmel JA, Patel R, Bhatt DL, Cilingiroglu M, Pinto DS, Dean LS, Grines CL. “Commentary on highlighted late breaking trials in interventional cardiology at ESC, VIVA, TCT, and AHA 2013”. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):95-103.
87. Marmagkiolis K, Lendel V, Cawich I, Leesar M, Feldman MD, Cilingiroglu M. “Optical coherence tomography to guide below-the-knee endovascular interventions”. Int J Cardiol. 2014 Oct 20;176(3):1336-8. 88. Mallikarjuna Rao Edupuganti M, Marmagkiolis K, Cilingiroglu M, Uretsky BF, Hakeem A. ”Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation”. Cardiovasc Revasc Med. Cardiovasc Revasc Med. 2014 Nov-Dec;15(8):414-20.
14
89. Marmagkiolis K, Lendel V, Cilingiroglu M. “OCT Evaluation of Directional Atherectomy compared to Balloon Angioplasty”. Cardiovasc Revasc Med. 2015 Feb 26. pii: S1553-8389(15)00058-5.
90. Cilingiroglu M, Marmagkiolis K. “Should MitraClip be preferred over surgery in high-risk patients with severe MR and CKD?”. Catheter Cardiovasc Interv. 2015 Apr;85(5):904-5.
91. Cilingiroglu M, Patel RA, Dean LS. “Late breaking trials of 2014 in structural heart disease and peripheral arterial disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA”. Catheter Cardiovasc Interv. 2015 Apr 9. doi: 10.1002/ccd.25941. [Epub ahead of print].
92. Cilingiroglu M, Marmagkiolis K. “Optimizing endovascular stroke therapy: A primary PCI deja-vu?”. Catheter Cardiovasc Interv. 2015 May;85(6):1051-2.
93. Marmagkiolis K, Lendel V, Cilingiroglu M. “Endovascular management of pacemaker-induced brachio-axilo-subclavian venous chronic total occlusion” J Interv Card Electrophysiol. 2015 Oct;44(1):87-8. 94. Marmagkiolis K, Lendel V, Cilingiroglu M. “Endovascular management of IVC syndrome after IVC filter placement”. Rev Port Cardiol 2015 Sep;34(9):555.e1-4.
95. Marmagkiolis K, Cilingiroglu M. “Time to expand the Mitra-Clip indications”. Catheter Cardiovasc Interv. 2015 Oct;86:(4):736-7. 96. Marmagkiolis K, Arzamendi D, Goktekin O, Cilingiroglu M. “Structural heart interventions training in Europe”. Int J Cardiol. 2015 Sep21;202:532- 534.
97. Marmagkiolis K, Hakeem A, Cilingiroglu M, Gundogdu B, Iliescu C, Tsitlakidou D, Katramados A. “Safety and Efficacy of Stent Retriever for the Management of Acute Stroke: Comprehensive Review and Meta-Analysis”. JACC Cardiovasc Interv. 2015 Oct6.pii:S1936-8798(15)01264-9. 98. Ali O, Marmagkiolis K, Cilingiroglu M. “Combined rotational atherectomy and aortic balloon valvuloplasty as a bridge to transcatheter aortic valve replacement”. Rev Port Cardiol. 2015 Dec;34(12):775.e1-4. 99. Iliescu C, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Marmagkiolis K. “SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory
(Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista)”. Catheter Cardiovasc Interv. 2015 Dec 23. doi: 10.1002/ccd.26375.
100. Iliescu CA, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas KP, Leesar MA, Marmagkiolis K. “SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory
(endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista)”. Catheter Cardiovasc Interv. 2016 Jan 12. doi: 10.1002/ccd.26379.
15
101. Cilingiroglu M, Marmagkiolis K. “Predictors of mortality after mitraclip therapy”. Catheter Cardiovasc Interv. 2016 Feb 15;87(3):476-7. doi: 10.1002/ccd.26431.
102. Marmagkiolis K, Cilingiroglu M. “OCT-Guided PCI: Are We There Yet?”. J Invasive Cardiol. 2016 Mar;28(3):98.
103. Herrmann J, Yang EH, Iliescu CA, Cilingiroglu M, Charitakis K, Hakeem A, Toutouzas K, Leesar MA, Grines CL, Marmagkiolis K. “ Vascular Toxicities of Cancer Therapies: The Old and the New - An Evolving Avenue”. Circulation. 2016 Mar 29;133(13):1272-89. 104. Aksoy O, Paixao AR, Marmagkiolis K, Mego D, Rollefson WA, Cilingiroglu M. “ Aortic annular rupture during TAVR: Mini review”. Cardiovasc Revasc Med. 2016 Apr-May;17(3):199-201.
105. Marmagkiolis K, Cilingiroglu M. “Rivaroxaban for the treatment of saphenous vein graft thrombosis”. Rev Port Cardiol. 2016 Jul-Aug;35(7- 8):447.
106. Cilingiroglu M, Marmagkiolis K.” A glimpse into the
Contact this candidate